EC Number |
Inhibitors |
Structure |
---|
2.7.1.21 | (2Z)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)but-2-en-1-yl 3,3-dimethylbutanoate |
IC50: 0.028 mM |
|
2.7.1.21 | (2Z)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)but-2-en-1-yl 3,3-dimethylbutanoate |
IC50: above 0.5 mM |
|
2.7.1.21 | (2Z)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)but-2-en-1-yl benzoate |
IC50: 0.03 mM |
|
2.7.1.21 | (2Z)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)but-2-en-1-yl benzoate |
IC50: above 0.5 mM |
|
2.7.1.21 | (2Z)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)but-2-en-1-yl diphenylacetate |
IC50: 0.0046 mM |
|
2.7.1.21 | (2Z)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)but-2-en-1-yl diphenylacetate |
IC50: 0.281 mM |
|
2.7.1.21 | (2Z)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)but-2-en-1-yl dodecanoate |
IC50: 0.019 mM |
|
2.7.1.21 | (2Z)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)but-2-en-1-yl dodecanoate |
IC50: above 0.5 mM |
|
2.7.1.21 | (2Z)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)but-2-en-1-yl heptanoate |
IC50: 0.011 mM |
|
2.7.1.21 | (2Z)-4-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)but-2-en-1-yl heptanoate |
IC50: 0.42 mM |
|